%0 Journal Article
%T Oropharyngeal candidiasis and resistance to antifungal drugs in patients receiving radiation for head and neck cancer
%A Maryam Rad DMD
%A MSc
%A Seyyed Amin Ayatollahi Mousavi PhD
%A Shahla Kakoei DDS
%A MSc
%A Maryam Bahador MD
%J Journal of Oral Health and Oral Epidemiology
%D 2012
%I Kerman University of Medical Sciences
%X BACKGROUND: Oropharyngeal candidiasis is a common infection in patient receiving radiotherapy for head and neckcancer. Accurate and rapid identification of candida species is very important in clinical laboratory, because theincidence of candidiasis continues to rise after radiotherapy. The genus Candida has about 154 species that showdifferent level of resistance to antifungal drugs and have high degree of phenotypic similarity. The aim of this study wasto investigate oral yeast colonization and infection and resistance to antifungal drugs in these patients.METHODS: Thirty patients receiving a 6-week course of radiation therapy for treatment of head and neck cancer at theOncology Unit in Shafa Hospital, in 2008, were enrolled in the study. Specimens from patients were cultured weeklyfor Candida. All isolates were plated on CHROM agar and RPMI-based medium. They were subcultured and submittedfor antifungal susceptibility testing (nystatin, fluconazole, clotrimazole and ketoconazole) and molecular typing.RESULTS: Infection (clinical and microbiological evidence) occurred in 50% of the patients and Candida colonization(only microbiological evidence) occurred in 70% of subjects in the first week. Candida albicans alone was isolated in94.9% of patient visits with positive cultures. Candida tropicalis was isolated from 5.1% of patient visits with positivecultures. All isolates were susceptible to nystatin, but did not respond to the other antifungal drugsCONCLUSIONS: The irradiation-induced changes of the intraoral environment such as xerostomia lead to increasedintraoral colonization by Candida species. All yeast isolates were susceptible to nystatin. Thus prophylactic therapywith nystatin should be considered for these patients.
%K Oropharyngeal candidiasis
%K radiation
%K colonization
%K antifungal drugs
%K cancer
%U http://johoe.kmu.ac.ir/index.php/johoe/article/view/10/6